Zeno Management, Inc

Loxo Oncology in San Diego, CA, is a biopharmaceutical company dedicated to developing targeted cancer therapies. Their focus lies in advancing precision medicine to address the needs of patients with genetically defined cancers. With a commitment to innovation and collaboration, Loxo Oncology strives to bring novel treatment options to the forefront of oncology research. Through their cutting-edge approach, they aim to make a meaningful impact on the lives of individuals affected by cancer. Generated from their business information

Poseida Therapeutics, a member of the Roche Group, is at the forefront of innovation in cell and gene therapies, focusing on developing bold solutions to transform treatment paradigms for life-threatening cancers and genetic diseases. The company's advanced genetic engineering technologies, including a non-viral piggyBac DNA Delivery System and Cas-CLOVER Site-Specific Gene Editing System, offer promising new hope for patients through precise and effective treatments. By targeting specific cell populations, Poseida Therapeutics aims to enhance allogeneic CAR-T therapies and seek functional cures for rare genetic diseases. Their commitment to advancing these pioneering technologies positions them as a leader in the ongoing evolution of therapeutic strategies in the medical field. Generated from the website

Arcturus Therapeutics is a global late-stage clinical messenger RNA medicines and vaccines company based in San Diego, CA. They are focused on the discovery, development, and commercialization of therapeutics for rare diseases and vaccines, utilizing proprietary technologies and validating partnerships. The company has built a multicultural team with deep expertise in delivery and RNA-based therapeutics. They have developed an exciting COVID-19 vaccine candidate that aims to make a positive difference in the pandemic, with the goal of protecting people around the world, regardless of their origin.Generated from the website